Login

The President Director of PT Solusi Tunas Pratama Tbk shares his career journey. 00:10:00

Share On Facebook Share On Twitter

President Director/CEO/Secy, Solusi Tunas Pratama Tbk PT.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights from Nixu Cybersecurity Index 2023: Key Findings & Trends | Teemu Salmi , CEO at Nixu
00:10:00
Argentina's Silver Boom: Salta Leads in Global Investment
00:10:00
Customer Success Story | Robert Keane, CEO, Cimpress PLCCMPR:NSQ
00:10:00
10 Common Questions About Audits
00:10:00
The Bright Side of Venture Capital|Albert Wenger, Managing Partner,Union Square Ventures
00:10:00
Lomiko Metals: Building North America’s Largest Undeveloped Graphite Asset with Non-Dilutive Government Backing|Gordana Slepcev,CEO,Lomiko Metals Inc
00:10:00
Market Update & Federal Programs Overview
00:10:00
Exploring Unique Features and Functions of New Products
00:10:00
Interview with CAE CEO Marc Parent: Navigating Aviation, Defence, and Healthcare Development | Marc Parent - CEO of CAE Inc.
00:10:00
CAE Inc. (TSX:CAE) is captured in a filming session dated September 20, 2016, accessible through
00:10:00
Global network and operational resources make us more valuable than capital alone|Reeta, Co-Founder,The Silverfern Group, Inc.
00:10:00
"John Richards from Brickability Group PLC (AIM: BRCK) discusses winning the AIM 'Transaction of the Year Award' with Proactive London."|John Richards is currently the Non-Executive Chairman at Brickability Group Plc

© 2017 - Neuhu+